| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.74▲ | 2.74▲ | 2.75▼ | 2.80▼ | 2.70▼ |
| MA10 | 2.77▼ | 2.80▼ | 2.82▼ | 2.89▼ | 2.59▲ |
| MA20 | 2.83▼ | 2.88▼ | 2.91▼ | 2.86▼ | 2.68▼ |
| MA50 | 2.93▼ | 2.92▼ | 2.90▼ | 2.60▲ | 3.08▼ |
| MA100 | 2.85▼ | 2.75▼ | 2.67▲ | 2.73▼ | 6.16▼ |
| MA200 | 2.64▲ | 2.56▲ | 2.57▲ | 2.93▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.009▼ | -0.020▼ | -0.030▼ | -0.042▼ | 0.087▲ |
| RSI | 31.413▼ | 37.233▼ | 39.251▼ | 45.114▼ | 47.407▼ |
| STOCH | 2.557▼ | 1.536▼ | 1.471▼ | 30.444 | 62.326 |
| WILL %R | -96.970▼ | -97.500▼ | -98.113▼ | -74.648 | -43.983 |
| CCI | -61.499 | -82.540 | -98.123 | -257.350▼ | 62.333 |
|
Monday, June 09, 2025 09:22 AM
Explore the NASDAQ:LIPO financials. Find the Lipella Pharmaceuticals financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers ...
|
|
Wednesday, June 04, 2025 05:39 AM
Dr. Jonathan Kaufman, Chief Executive Officer and Co-Founder of Lipella, said, “We are pleased to renew our collaboration with Cook MyoSite, a trusted partner with a strong track record in ...
|
|
Tuesday, May 20, 2025 01:52 AM
P ITTSBURGH - Lipella Pharmaceuticals Inc. (NASDAQ:LIPO), a biotech firm specializing in novel therapies for medical conditions lacking adequate treatments, has received FDA approval for an ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 2.68 | 2.68 | 2.46 | 2.64 | 21,300 |
| 12/06/25 | 2.76 | 2.79 | 2.68 | 2.71 | 13,300 |
| 11/06/25 | 2.93 | 2.93 | 2.80 | 2.80 | 12,200 |
| 10/06/25 | 2.935 | 2.935 | 2.935 | 2.935 | 1,866 |
| 09/06/25 | 2.99 | 2.99 | 2.835 | 2.91 | 20,300 |
| 06/06/25 | 3.00 | 3.10 | 2.80 | 2.99 | 50,900 |
| 05/06/25 | 2.99 | 3.17 | 2.88 | 3.09 | 54,200 |
| 04/06/25 | 2.87 | 3.00 | 2.75 | 2.965 | 45,500 |
| 03/06/25 | 2.93 | 3.00 | 2.7669 | 2.93 | 16,264 |
| 02/06/25 | 2.88 | 2.953 | 2.79 | 2.945 | 4,924 |
|
|
||||
|
|
||||
|
|